InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
24
T+90 hit rate
67%
T+90 mean return
+16.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Stout Jay S, Chief Technology Officer. Director active across 1 company, notably Immunovant, Inc.. Aggregated, 27 reports have been recorded. Split: 0 buy · 24 sells. Total volume traded: €1.4m. Activity tracked since 17 April 2023. The latest transaction was disclosed on 23 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations27 total
33,277 sharesCommon StockSEC:0001764013-26-000074:0
6,723 sharesCommon StockSEC:0001764013-26-000074:1
2,754 shares@ US$29.620.0012% mcap7.7% of flowCommon StockSEC:0001764013-26-000055
2,754 shares@ US$29.620.0012% mcap7.7% of flowCommon StockSEC:0001764013-26-000055:0
8,614 shares@ US$24.830.0033% mcap20.3% of flowCommon StockSEC:0001702969-26-000006:0
8,614 shares@ US$24.830.0033% mcap20.3% of flowCommon StockSEC:0001702969-26-000006
1,977 shares@ US$26.034.9% of flowCommon StockSEC:0001702969-26-000002
1,977 shares@ US$26.030.0008% mcap4.9% of flowCommon StockSEC:0001702969-26-000002:0
1,148 shares@ US$26.510.0005% mcap2.9% of flowCommon StockSEC:0001764013-26-000002:0
1,148 shares@ US$26.512.9% of flowCommon StockSEC:0001764013-26-000002
2,520 shares@ US$19.034.6% of flowCommon StockSEC:0001764013-25-000143
2,520 shares@ US$19.030.0007% mcap4.6% of flowCommon StockSEC:0001764013-25-000143:0
1,585 shares@ US$16.302.5% of flowCommon StockSEC:0001764013-25-000138
1,585 shares@ US$16.300.0004% mcap2.5% of flowCommon StockSEC:0001764013-25-000138:0
2,805 shares@ US$18.150.0008% mcap4.8% of flowCommon StockSEC:0001764013-25-000115:0
2,805 shares@ US$18.154.8% of flowCommon StockSEC:0001764013-25-000115
1,519 shares@ US$17.240.0004% mcap2.5% of flowCommon StockSEC:0001764013-25-000108:0
1,519 shares@ US$17.242.5% of flowCommon StockSEC:0001764013-25-000108
1,925 shares@ US$14.791.8% of flowCommon StockSEC:0001764013-25-000083:0
5,004 shares@ US$12.994.3% of flowCommon StockSEC:0001764013-25-000069:0
76,181 shares0Common StockSEC:0001764013-25-000055:0
2,195 shares@ US$23.593.6% of flowCommon StockSEC:0001764013-25-000019:0
2,740 shares@ US$29.535.4% of flowCommon StockSEC:0001764013-24-000178:0
2,813 shares@ US$27.765.2% of flowCommon StockSEC:0001764013-24-000143:0
7,239 shares@ US$28.9014.2% of flowCommon StockSEC:0001764013-24-000087:0
25 of 27 declarations
About Stout Jay S
Jay S Stout is the Chief Technology Officer of Immunovant, Inc.
